A1CF | APOBEC1 complementation factor | | | | |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |
AADAC | Arylacetamide deacetylase | | | | |
|
| | Tissue enhanced | 0 |
AADAT | Aminoadipate aminotransferase | | | | |
|
| Plasma membrane Vesicles | Tissue enhanced | 0 |
ABAT | 4-aminobutyrate aminotransferase | | | | |
|
| | Tissue enhanced | 0 |
ABCA6 | ATP-binding cassette, sub-family A (ABC1), member 6 | | | | | |
| | Tissue enhanced | 0 |
ABCC6 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 | | | | | |
| Plasma membrane | Tissue enhanced | 0 |
ACOX2 | Acyl-CoA oxidase 2, branched chain | | | | |
|
| | Tissue enhanced | 0 |
ACSM1 | Acyl-CoA synthetase medium-chain family member 1 | | | | |
|
| | Tissue enhanced | 0 |
ACSM3 | Acyl-CoA synthetase medium-chain family member 3 | | | | |
|
| | Tissue enhanced | 0 |
ADAMTS13 | ADAM metallopeptidase with thrombospondin type 1 motif, 13 | | | | |
|
| | Tissue enhanced | 0 |
ADRA1A | Adrenoceptor alpha 1A | | | | |
|
| | Tissue enhanced | 0 |
AGMO | Alkylglycerol monooxygenase | | | | |
|
| | Tissue enhanced | 0 |
AGT | Angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | | | | |
|
| | Tissue enhanced | 0 |
AL358113.1 | Tight junction protein 2 (Zona occludens 2) isoform 1 variant; Uncharacterized protein | | | | | |
| | Tissue enhanced | 0 |
ALDH1L1 | Aldehyde dehydrogenase 1 family, member L1 | | | | |
|
| | Tissue enhanced | 0 |
AMDHD1 | Amidohydrolase domain containing 1 | | | | |
|
| Plasma membrane Cytoskeleton (Actin filaments) Focal Adhesions | Tissue enhanced | 0 |
ANGPTL4 | Angiopoietin-like 4 | | | | |
|
| | Tissue enhanced | 0 |
ANGPTL6 | Angiopoietin-like 6 | | | | |
|
| | Tissue enhanced | 0 |
AOX1 | Aldehyde oxidase 1 | | | | |
|
| Cytoplasm | Tissue enhanced | 0 |
APOC3 | Apolipoprotein C-III | | | | | |
| | Tissue enhanced | 0 |
ARG1 | Arginase 1 | | | | |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |
ARSE | Arylsulfatase E (chondrodysplasia punctata 1) | | | | | |
| | Tissue enhanced | 0 |
ART4 | ADP-ribosyltransferase 4 (Dombrock blood group) | | | | |
|
| | Tissue enhanced | 0 |
ASPDH | Aspartate dehydrogenase domain containing | | | | |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |
ASPG | Asparaginase homolog (S. cerevisiae) | | | | | |
| | Tissue enhanced | 0 |
ASS1 | Argininosuccinate synthase 1 | | | | |
|
| Nucleus but not nucleoli Cytoplasm | Tissue enhanced | 0 |
AZGP1 | Alpha-2-glycoprotein 1, zinc-binding | | | | |
|
| | Tissue enhanced | 0 |
BCHE | Butyrylcholinesterase | | | | |
|
| | Tissue enhanced | 0 |
BCO2 | Beta-carotene oxygenase 2 | | | | |
|
| Vesicles Cytoskeleton (Actin filaments) Nuclear membrane | Tissue enhanced | 0 |
BLOC1S5-TXNDC5 | BLOC1S5-TXNDC5 readthrough (NMD candidate) | | | | | |
| | Tissue enhanced | 0 |
C1orf168 | Chromosome 1 open reading frame 168 | | | | |
|
| | Tissue enhanced | 0 |
C2 | Complement component 2 | | | | |
|
| | Tissue enhanced | 0 |
C2orf72 | Chromosome 2 open reading frame 72 | | | | |
|
| | Tissue enhanced | 0 |
C6orf123 | Chromosome 6 open reading frame 123 | | | | |
|
| | Tissue enhanced | 0 |
CBS | Cystathionine-beta-synthase | | | | |
|
| Nucleoli Vesicles | Tissue enhanced | 0 |
CCL15-CCL14 | CCL15-CCL14 readthrough (NMD candidate) | | | | | |
| | Tissue enhanced | 0 |
CDO1 | Cysteine dioxygenase type 1 | | | | |
|
| Nucleus but not nucleoli | Tissue enhanced | 0 |
CFH | Complement factor H | | | | |
|
| | Tissue enhanced | 0 |
CFI | Complement factor I | | | | |
|
| | Tissue enhanced | 0 |
CHRNA4 | Cholinergic receptor, nicotinic, alpha 4 (neuronal) | | | | |
|
| | Tissue enhanced | 0 |
CLDN1 | Claudin 1 | | | | |
|
| | Tissue enhanced | 0 |
COLEC11 | Collectin sub-family member 11 | | | | |
|
| Cytoplasm Cytoskeleton (Microtubules) | Tissue enhanced | 0 |
CRHBP | Corticotropin releasing hormone binding protein | | | | |
|
| | Tissue enhanced | 0 |
CTH | Cystathionase (cystathionine gamma-lyase) | | | | |
|
| Nucleus Cytoplasm | Tissue enhanced | 0 |
CXCL2 | Chemokine (C-X-C motif) ligand 2 | | | | | |
| | Tissue enhanced | 0 |
CYP27A1 | Cytochrome P450, family 27, subfamily A, polypeptide 1 | | | | |
|
| | Tissue enhanced | 0 |
CYP2C18 | Cytochrome P450, family 2, subfamily C, polypeptide 18 | | | | | |
| | Tissue enhanced | 0 |
CYP2C19 | Cytochrome P450, family 2, subfamily C, polypeptide 19 | | | | |
|
| | Tissue enhanced | 0 |
CYP2J2 | Cytochrome P450, family 2, subfamily J, polypeptide 2 | | | | | |
| | Tissue enhanced | 0 |
CYP39A1 | Cytochrome P450, family 39, subfamily A, polypeptide 1 | | | | |
|
| | Tissue enhanced | 0 |